Markets
News
Analysis
User
24/7
Economic Calendar
Education
Data
- Names
- Latest
- Prev
【Bristol-Myers Squibb'S Three Innovative Drugs Have Been Included In The 2024 National Medical Insurance Catalog.】The 2024 National Medical Insurance Catalog Released Today Shows That Three Innovative Drugs From Bristol-Myers Squibb Have Been Included In The Catalog, Including The World'S First And Currently Only Approved Cardiac Myosin Inhibitor Mavacamten (Maraviroc Capsules) For The Treatment Of Obstructive Hypertrophic Cardiomyopathy, The World'S First And Currently Only Approved Oral Tyk2 Allosteric Inhibitor Zunsemetin (Deucravacitinib Tablets) For The Treatment Of Moderate To Severe Plaque Psoriasis, And The World'S First And Currently Only Approved Erythroid Maturation Agent Luspatercept (Injection Of Roxadustat) For The Treatment Of Β-Thalassemia
Quick access to 24/7
Quick access to more editor-selected real-time news
Exclusive video for free
FastBull VIPject team is dedicated to create exclusive videos
Follow More Symbols
You can add more symbols to your watchlist.
More comprehensive macro data and economic indicators
More comprehensive historical data on indicators to help analyze macro markets
Member-only Database
Comprehensive forex, commodity, and equity market data